Alpha Signal Monitor - Daily Market Briefing | February 19, 2026
Daily Market Research Report
February 19, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Gold ETFs Outlook — As of February 19, 2026
Trading Idea: Buy Rationale (TL;DR): Major banks (Goldman Sachs, J.P. Morgan, UBS, Bank of America) remain structurally bullish on gold into 2H26 amid ongoing central-bank accumulation, expectations for lower real rates, and portfolio diversification demand. While near‑term volatility has risen after the early‑February pullback below $5,000/oz, the prevailing 2026 targets imply mid‑single to low‑20% upside from current levels for GLD/IAU/BAR exposure, with JPM flagging gold as a highest‑conviction long and UBS guiding to ~$5,900 by year‑end. (businessinsider.com)
Spot gold briefly topped $5,000/oz in February before slipping below that level; markets are focused on inflation data and the policy path under the new Fed leadership, with real rates still expected to drift lower over 2026—conditions that historically support ETF demand. Central‑bank demand and diversification away from the USD remain key pillars cited by multiple CIO/research teams. (marketwatch.com)
Key Drivers - Official‑sector (central bank) buying expected to stay elevated in 2026; JPM models ~585 tonnes/quarter of combined investor + CB demand. (jpmorgan.com) - Falling/softer real rates and a weaker USD lower the opportunity cost of holding non‑yielding gold and historically spur ETF inflows. (ubs.com) - Portfolio diversification and ‘debasement’ hedging demand from private investors alongside geopolitical risk. (businessinsider.com) - Constrained mine supply response vs. strong price momentum; limited capex super‑cycle in mining. (morganstanley.com)
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Overweight/Bullish | $5,400/oz by end‑2026 | GS frames the rally as gold‑specific (not a broad commodity super‑cycle), driven by central‑bank buying, lower rates, and ‘debasement’ hedging; maintains a bullish path to $5,400 by Dec‑2026. (businessinsider.com) | 2026-02-16 | Business Insider, Feb 16, 2026. (businessinsider.com) |
| Morgan Stanley | Positive | $4,400/oz by end‑2026 (revised up from $3,313) | MS expects the rally to extend into 2026 on weaker USD, strong ETF/CB demand; highlights risks of demand destruction if prices stay elevated. (morganstanley.com) | 2025-10-22 | Morgan Stanley Research, Oct 22, 2025. (morganstanley.com) |
| JP Morgan | Overweight / “Highest‑conviction long” | $5,055/oz average in Q4‑2026; longer‑term path toward ~$6,000/oz | JPM expects sustained investor + central‑bank demand (~585t/quarter in 2026) to push prices toward $5,000+ by year‑end 2026. (jpmorgan.com) | 2025-12-16 | J.P. Morgan Global Research, Dec 16, 2025. (jpmorgan.com) |
| Bank of America | Bullish | $5,000/oz in 2026 (avg ~ $4,400) | BofA lifted its 2026 outlook to $5,000/oz, citing deficits, fiscal risks and an easing cycle; acknowledges near‑term correction risk but sees further upside next year. (investing.com) | 2025-10-13 | Reuters via Investing.com, Oct 13, 2025. (investing.com) |
| Citigroup | Neutral/Cautious | 2026 avg ~$3,250; near‑term (0–3m) $3,800–$4,000 as of 4Q25 outlook | Citi downgraded medium‑term averages in late‑2025 but raised short‑term targets on tightness/China buying; base case peaks into early‑2026 before rotation out of gold as growth firms. (investing.com) | 2025-12-08 | Reuters (Oct 28, 2025) and Citi Research ‘Commodities Market Outlook 4Q’25’ (Dec 8, 2025). (investing.com) |
| UBS | Attractive / Overweight | ~$5,900/oz by end‑2026 (CIO House View) | UBS CIO expects the rally to resume after recent volatility, with lower real rates and persistent CB demand supporting gold and ETF inflows; year‑end 2026 around $5,900. (ubs.com) | 2026-02-12 | UBS CIO House View Key Messages (week of Feb 12, 2026). (ubs.com) |
| HSBC | Neutral (near‑term upside, H2 caution) | High ~$5,050 in H1‑2026; 2026 avg ~$4,587; YE ~$4,450 | HSBC sees a spike above $5,000 in H1’26 on geopolitics/debt risks, but trims the 2026 average and warns of a potential H2 correction within a wide $3,950–$5,050 range. (mining.com) | 2026-01-09 | MINING.com summary of HSBC note, Jan 9, 2026. (mining.com) |
| Deutsche Bank | Positive | 2026 avg ~$4,450; range $3,950–$4,950 | DB raised its 2026 forecast on stabilizing investor flows, persistent CB demand and supportive technicals; still flags risks from fewer Fed cuts or slower reserve buying. (investing.com) | 2025-11-26 | Reuters via Investing.com, Nov 26, 2025. (investing.com) |
Risk Considerations - Upside in real yields or a more hawkish‑than‑expected Fed could pressure gold and prompt ETF outflows. (marketwatch.com) - A stronger USD or easing in geopolitical tensions could sap safe‑haven demand and reverse some 2025–26 inflows. (ubs.com) - Positioning/volatility shocks (e.g., futures margin hikes, thin liquidity) can drive sharp drawdowns even in an up‑trend. (businesstoday.in) - Potential moderation of central‑bank purchases at higher price levels would weaken a key pillar of support. (bloomberg.com)
Given the aggregate 2026 targets and supportive macro, we favor maintaining or adding core gold ETF exposure (GLD/IAU/BAR) on dips, sizing for elevated volatility. Watchpoints: inflation prints, Fed path, USD, and any sign of central‑bank demand fatigue. Positioning should lean strategic (core allocation), with tactical overlays recognizing the wide ranges several houses now project. (marketwatch.com)
Stock Ratings — US Tech Megacaps — Street Targets and Ratings (as of February 19, 2026)
Compiled from the latest publicly reported research items by GS, MS, JPM, BAC, C, and WFC. Where banks use terms like Overweight/Equal Weight/Underweight, they are mapped to Buy/Hold/Sell equivalents in notes.
AAPL - Apple Inc.
Most majors remain constructive; targets cluster around the low-$300s.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $330 | 2026-02-03 | Reiterate Buy; cites accelerating App Store spend. | https://m.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-with-330-price-target-93CH-4482636?ampMode=1 |
| Morgan Stanley | Buy | $252 | 2025-03-12 | Overweight mapped to Buy; PT cut amid AI Siri timing concerns. | https://www.investors.com/news/technology/apple-stock-price-target-cut-morgan-stanley/ |
| JP Morgan | Buy | $315 | 2026-01-26 | Overweight mapped to Buy. | https://www.marketbeat.com/instant-alerts/apple-nasdaqaapl-price-target-raised-to-31500-at-jpmorgan-chase-co-2026-01-26/ |
| Bank of America | Buy | $320 | 2025-10-29 | Raised on 5‑year outlook/AI at the edge. | https://finance.yahoo.com/news/apple-stock-target-raised-bofa-135505743.html |
| Citigroup | Buy | $330 | 2025-12-09 | Raised on iPhone 17 cycle strength. | https://www.investing.com/news/stock-market-news/citi-raises-apple-price-target-on-firmer-upgrade-cycle-iphone-17-strength-4398652 |
| Wells Fargo | Buy | $300 | 2025-12-29 | Overweight mapped to Buy. | https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-overweight-rating-on-apple-stock-amid-china-gains-93CH-4423681 |
Consensus View - Rating: Buy, Target Price: $308 - 5x Buy/Overweight and 1x Buy-equivalent; average target ~$308.
MSFT - Microsoft Corp.
Targets largely $520–$700; AI exposure keeps broad Buy stance intact.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $655 | 2026-01-20 | Maintains Buy post power-cost headlines. | https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-maintained-at-655-by-goldman-sachs-93CH-4454081 |
| Morgan Stanley | Buy | $650 | 2026-01-14 | Overweight mapped to Buy; CIO survey read-throughs. | https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158 |
| JP Morgan | Buy | $575 | 2025-10-30 | Overweight mapped to Buy. | https://www.gurufocus.com/news/3173478/jp-morgan-raises-microsoft-msft-price-target-to-575-msft-stock-news |
| Bank of America | Buy | $520 | 2026-01-26 | Cut from $640; Buy maintained. | https://www.marketbeat.com/instant-alerts/bank-of-america-cuts-microsoft-nasdaqmsft-price-target-to-52000-2026-01-26/ |
| Citigroup | Buy | $635 | 2026-01-29 | Trim from $660; Buy maintained. | https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-given-new-63500-price-target-at-citigroup-2026-01-29/ |
| Wells Fargo | Buy | $700 | 2025-10-30 | Overweight mapped to Buy. | https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-700-from-675-at-wells-fargo-93CH-4318741 |
Consensus View - Rating: Buy, Target Price: $623 - All six at Buy/Overweight; average target ~$623.
GOOGL - Alphabet Inc.
Street lifts 2026 targets post Q4; most at Buy, WFC neutral.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $375 | 2026-01-13 | Raised target; constructive on Cloud/Search/AI. | https://www.gurufocus.com/news/4109066/googl-goldman-sachs-maintains-buy-rating-raises-price-target-googl-stock-news |
| Morgan Stanley | Buy | $205 | 2025-07-21 | Overweight mapped to Buy; valuation rolled to mid‑2026. | https://www.investing.com/news/analyst-ratings/alphabet-stock-price-target-raised-to-205-from-185-at-morgan-stanley-93CH-4143076 |
| JP Morgan | Buy | $395 | 2026-02-05 | Overweight mapped to Buy; ‘best idea’. | https://www.marketbeat.com/instant-alerts/alphabet-nasdaqgoogl-given-new-39500-price-target-at-jpmorgan-chase-co-2026-02-05/ |
| Bank of America | Buy | $370 | 2026-02-06 | Reiterated Buy post-earnings. | https://www.thestreet.com/investing/stocks/bank-of-america-resets-google-stock-forecast-post-earnings |
| Citigroup | Buy | $390 | 2026-02-06 | Raised target; Buy maintained. | https://www.marketbeat.com/instant-alerts/citigroup-issues-positive-forecast-for-alphabet-nasdaqgoogl-stock-price-2026-02-06/ |
| Wells Fargo | Hold | $350 | 2026-01-12 | Equal Weight mapped to Hold; PT raised. | https://www.gurufocus.com/news/4106624/googl-wells-fargo-raises-alphabets-target-price-to-350-googl-stock-news |
Consensus View - Rating: Buy, Target Price: $348 - 5x Buy vs 1x Hold; average target ~$348.
AMZN - Amazon.com Inc.
After Feb 6 capex update, several trims but all six remain constructive.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $280 | 2026-02-06 | Cut from $300 post 2026 capex guide. | https://m.investing.com/news/analyst-ratings/goldman-sachs-lowers-amazon-stock-price-target-to-280-on-investment-cycle-93CH-4489716?ampMode=1 |
| Morgan Stanley | Buy | $300 | 2026-02-06 | Overweight mapped to Buy; trim from $315. | https://www.streetinsider.com/Analyst+PT+Change/Amazon.com+%28AMZN%29+PT+Lowered+to+%24300+at+Morgan+Stanley/25958773.html |
| JP Morgan | Buy | $265 | 2026-02-06 | Overweight mapped to Buy; lowered on higher capex. | https://www.tipranks.com/news/the-fly/amazon-com-price-target-lowered-to-265-from-305-at-jpmorgan-thefly |
| Bank of America | Buy | $286 | 2026-01-27 | Buy maintained; AWS outlook reset. | https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-lowered-to-286-by-bofa-on-aws-outlook-93CH-4466651 |
| Citigroup | Buy | $265 | 2026-02-09 | Lowered from $320; Buy maintained. | https://www.gurufocus.com/news/8599176/amzn-citigroup-lowers-price-target-but-maintains-buy-rating-amzn-stock-news |
| Wells Fargo | Buy | $305 | 2026-02-06 | Overweight mapped to Buy; Top Internet pick. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
Consensus View - Rating: Buy, Target Price: $284 - All six Buy/Overweight; average target ~$284.
NVDA - NVIDIA Corp.
Banks broadly positive into 2026 AI cycle; targets clustered ~$200–$275 (post‑split).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $240 | 2025-10-31 | ‘Beat and raise’ setup into prints. | https://finance.yahoo.com/news/goldman-sachs-expects-nvidia-beat-135658622.html |
| Morgan Stanley | Buy | $250 | 2025-12-01 | Overweight mapped to Buy; PT raised. | https://www.gurufocus.com/news/3228857/morgan-stanley-adjusts-nvidia-nvda-price-target-to-250-nvda-stock-news |
| JP Morgan | Buy | $215 | 2025-09-04 | Overweight mapped to Buy; demand > supply. | https://www.investing.com/news/analyst-ratings/nvidia-stock-rating-reiterated-by-jpmorgan-on-strong-data-center-demand-93CH-4224594 |
| Bank of America | Buy | $275 | 2025-10-29 | Raised after GTC; top pick. | https://finance.yahoo.com/news/analysts-lift-nvidia-price-targets-121925397.html |
| Citigroup | Buy | $210 | 2025-09-30 | Raised on AI spend outlook. | https://finance.yahoo.com/news/citi-lifts-nvidia-target-stronger-140202177.html |
| Wells Fargo | Buy | $265 | 2025-11-14 | Overweight mapped to Buy. | https://www.gurufocus.com/news/3209758/wells-fargo-raises-nvidia-nvda-price-target-to-265-nvda-stock-news |
Consensus View - Rating: Buy, Target Price: $243 - All six Buy/Overweight; average target ~$243 (split‑adjusted).
META - Meta Platforms Inc.
Spend-heavy AI roadmap keeps targets elevated; most remain Buy/Overweight.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $765 | 2025-01-30 | Raised post strong Q4 FY24. | https://www.investing.com/news/analyst-ratings/goldman-sachs-lifts-meta-stock-price-target-to-765-93CH-3838716 |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | Buy | $825 | 2026-01-29 | Overweight mapped to Buy; raised target. | https://coincodex.com/article/80949/meta-stock-prediction-jpmorgan-raises-target-to-825-as-ai-spending-drives-new-momentum/ |
| Bank of America | Buy | $690 | 2025-05-01 | Raised; Buy maintained. | https://www.tipranks.com/news/the-fly/meta-platforms-price-target-raised-to-690-from-640-at-bofa |
| Citigroup | Buy | $803 | 2025-06-20 | Named top pick; target lifted. | https://www.investopedia.com/meta-called-a-top-pick-by-citi-analysts-on-digital-ad-strength-11760351 |
| Wells Fargo | Buy | $754 | 2026-01-23 | Overweight mapped to Buy; PT trimmed on higher capex. | https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-lowered-to-754-at-wells-fargo-93CH-4463247 |
Consensus View - Rating: Buy, Target Price: $767 - 5 reported targets average ~$767; MS latest not found in public sources.
TSLA - Tesla Inc.
Views are split; MS/GS at Hold-equivalents, JPM/WFC Underweight post 2026 capex/FCF guide.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Hold | $405 | 2026-01-29 | Neutral mapped to Hold. | https://www.pricetargets.com/NASDAQ/TSLA/ |
| Morgan Stanley | Hold | $415 | 2026-01-29 | Equal Weight mapped to Hold; PT slightly cut. | https://www.pricetargets.com/NASDAQ/TSLA/ |
| JP Morgan | Sell | $145 | 2026-01-30 | Underweight mapped to Sell; trimmed after Q4. | https://www.tipranks.com/news/the-fly/tesla-price-target-lowered-to-145-from-150-at-jpmorgan-thefly |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | Sell | $125 | 2026-01-29 | Underweight mapped to Sell. | https://www.pricetargets.com/NASDAQ/TSLA/ |
Consensus View - Rating: Hold, Target Price: $273 - Mixed: 2x Hold, 2x Sell; average of available targets ~$273.
AVGO - Broadcom Inc.
AI networking/custom silicon momentum keeps stance positive; coverage uneven publicly.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $360 | 2025-09-05 | Reiterate Buy on AI momentum. | https://www.investing.com/news/analyst-ratings/broadcom-stock-holds-buy-rating-at-goldman-sachs-on-ai-momentum-93CH-4226196 |
| Morgan Stanley | Buy | - | 2025-10-14 | Overweight mapped to Buy; target not publicly available in cited item. | https://www.nasdaq.com/articles/morgan-stanley-maintains-broadcom-avgo-overweight-recommendation |
| JP Morgan | Buy | $325 | 2025-07-09 | Overweight mapped to Buy; reiterated. | https://www.investing.com/news/analyst-ratings/jpmorgan-reiterates-overweight-rating-on-broadcom-stock-amid-strong-ai-demand-93CH-4128085 |
| Bank of America | Buy | $500 | 2025-12-12 | Raised; BAC top pick. | https://www.investing.com/news/analyst-ratings/broadcom-stock-price-target-raised-to-500-by-bofa-on-ai-growth-93CH-4405225 |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - Rating: Buy, Target Price: $395 - Across available targets (GS/JPM/BAC); average ~$395.
TSM - Taiwan Semiconductor Manufacturing Company (TSMC)
Banks broadly positive on multi‑year AI/advanced‑node ramp; most targets issued in NT$.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | NT$2,330 | 2026-01-05 | Street‑high local‑line target; strong AI/packaging demand. | https://www.thestreet.com/investing/stocks/goldman-sachs-stuns-with-taiwan-semiconductor-stock-price-target |
| Morgan Stanley | Buy | NT$1,588 | 2025-09-30 | Overweight mapped to Buy; Street‑high at the time. | https://finance.yahoo.com/news/tsmc-stock-target-raised-morgan-121223698.html |
| JP Morgan | Buy | NT$2,100 | 2026-01-07 | Overweight mapped to Buy; stronger 2026 USD growth. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-tsmc-stock-price-target-to-nt2100-on-ai-growth-outlook-93CH-4434161 |
| Bank of America | Buy | NT$2,360 | 2026-01-15 | Raised; tech leadership and pricing power. | https://www.investing.com/news/analyst-ratings/tsmc-stock-price-target-raised-to-nt2360-by-bofa-on-tech-leadership-93CH-4450329 |
| Citigroup | Buy | NT$1,400 | 2025-07-17 | Raised post strong 2Q25. | https://www.investing.com/news/analyst-ratings/tsmc-stock-price-target-raised-to-nt1400-by-citi-on-strong-2q25-results-4140181 |
| Wells Fargo | - | - | - | - | - |
Consensus View - Rating: Buy, Target Price: NT$1,956 - Average of available NT$ targets from GS/MS/JPM/BAC/C.
Highlights
- Microsoft: GS $655 (Buy), MS $650 (Overweight) in Jan 2026; consensus ~$623.
- Alphabet: JPM $395 and Citi $390 (Buy) in early Feb 2026; consensus ~$348.
- Amazon: Post–Feb 6 capex update, all six stayed Buy; consensus ~$284.
- Apple: GS $330 (Feb 3, 2026) and Citi $330 (Dec 9, 2025); consensus ~$308.
- NVIDIA: All six at Buy/Overweight; consensus ~$243 (post‑split).
- Tesla: Split views — GS/MS Hold-equivalents; JPM/WFC Underweight; consensus target ~$273.
- TSMC: Multiple 2026 NT$ target hikes (BAC NT$2,360; JPM NT$2,100; GS NT$2,330).
Notes: Ratings mapped as Overweight=Buy, Equal Weight=Hold, Underweight=Sell. Targets shown in USD unless noted; TSM targets shown in NT$ as issued.
IPO Calendar
Timeframe: February 19, 2026 to March 19, 2026 (US equity markets)
As of February 19, 2026, the near-term US IPO slate is thin following an unusually busy early‑February window. The post‑Presidents’ Day period is in its typical seasonal lull as issuers finalize year‑end audits, and recent volatility has made timing more selective. Renaissance Capital’s latest Week Ahead notes no firm US IPOs scheduled in the immediate term, while larger deals like Clear Street were postponed; near‑term activity is most likely to come from recently filed biotechs that can launch on short notice. (renaissancecapital.com)
Generate Biomedicines, Inc. (GENB)
- Exchange: Nasdaq (proposed)
- Lead underwriters: Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, Piper Sandler & Co., Guggenheim Securities, LLC, Cantor Fitzgerald & Co.
- Business summary: Clinical‑stage generative biology company using an AI‑enabled protein design platform to engineer therapeutics; lead program GB‑0895 (anti‑TSLP) is in Phase 3 for severe asthma, with proceeds intended to fund Phase 3 execution and advance additional pipeline and platform work.
- Notes: Initial S‑1 filed February 4, 2026; Amendment No. 1 filed February 13, 2026. Terms and trade date not set as of February 19, 2026; company is eligible to launch a roadshow on short notice subject to market conditions.
- Sources: SEC Form S‑1 (Feb 4, 2026). (sec.gov), SEC Form S‑1/A (Feb 13, 2026). (sec.gov), Coverage summarizing proposed underwriters/ticker. (investing.com)
Salspera, Inc. (TKVA)
- Exchange: Nasdaq (proposed)
- Lead underwriters: Kingswood Capital Markets
- Business summary: Clinical‑stage immuno‑oncology company developing live biotherapeutics; lead candidate Saltikva is an attenuated Salmonella engineered to express IL‑2 for solid tumors (initial focus: Stage IV metastatic pancreatic cancer) moving toward pivotal study.
- Notes: Initial S‑1 filed February 2, 2026; preliminary deal size placeholder disclosed; no price range, share count or trade date as of February 19, 2026.
- Sources: Renaissance Capital issuer profile and file date. (renaissancecapital.com), Media summary of S‑1 and proposed ticker/underwriter. (tradingview.com), SEC filing log noting Form S‑1 submission (Feb 2, 2026). (streetinsider.com)
Motive Technologies, Inc. (MTVE)
- Exchange: NYSE (proposed)
- Lead underwriters: J.P. Morgan, Citigroup, Barclays, Jefferies, RBC Capital Markets, Citizens Capital Markets, KeyBanc Capital Markets, Société Générale, Wolfe | Nomura Alliance
- Business summary: AI‑powered fleet and operations management software platform serving logistics, construction, energy and other physical‑operations industries (driver safety, telematics, spend/workforce management).
- Notes: Public S‑1 filed December 23, 2025; share count and price range not yet set. Roadshow could launch on short notice once conditions are favorable; no firm date as of February 19, 2026.
- Sources: Company press release (Business Wire) listing proposed exchange and underwriting syndicate. (markets.financialcontent.com), SEC Form S‑1 (Dec 23, 2025). (sec.gov), Context on filing and proposed ticker. (investopedia.com)
Clear Street Group Inc. (CLRS)
- Expected listing date: February 13, 2026 (postponed)
- Price range: $26.00 – $28.00 (revised from $40.00 – $44.00)
- Shares offered: 13,000,000 (revised from 23,809,524)
- Exchange: Nasdaq Global Select (approved)
- Lead underwriters: Goldman Sachs & Co. LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC, UBS Securities LLC, Clear Street LLC
- Business summary: Financial infrastructure technology firm and prime brokerage building a cloud‑native, end‑to‑end capital markets platform (clearing, custody, financing, risk and related services).
- Notes: IPO postponed on February 13, 2026 amid market volatility after cutting terms from 23.8M shares at $40–$44 to 13.0M shares at $26–$28; BlackRock had indicated non‑binding interest of up to $200 million. No new date set; could relaunch if conditions stabilize. (ft.com)
- Sources: SEC S‑1/A (Feb 10, 2026) showing 23,809,524 shares at $40–$44. (sec.gov), SEC S‑1/A (Feb 12, 2026) showing 13,000,000 shares at $26–$28 and Nasdaq approval for CLRS. (sec.gov), Underwriting Agreement exhibit listing bookrunners. (sec.gov), Postponement coverage. (ft.com)
US IPOs typically set firm pricing/trade dates only 7–10 days before listing, and calendars change quickly with market conditions. Data above reflects filings and calendars available as of February 19, 2026; verify final terms closer to launch. (renaissancecapital.com)
Sources
- Stock Ratings: https://coincodex.com/article/80949/meta-stock-prediction-jpmorgan-raises-target-to-825-as-ai-spending-drives-new-momentum/, https://finance.yahoo.com/news/analysts-lift-nvidia-price-targets-121925397.html, https://finance.yahoo.com/news/apple-stock-target-raised-bofa-135505743.html, https://finance.yahoo.com/news/citi-lifts-nvidia-target-stronger-140202177.html, https://finance.yahoo.com/news/goldman-sachs-expects-nvidia-beat-135658622.html, https://finance.yahoo.com/news/tsmc-stock-target-raised-morgan-121223698.html, https://m.investing.com/news/analyst-ratings/goldman-sachs-lowers-amazon-stock-price-target-to-280-on-investment-cycle-93CH-4489716?ampMode=1, https://m.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-with-330-price-target-93CH-4482636?ampMode=1, https://www.gurufocus.com/news/3173478/jp-morgan-raises-microsoft-msft-price-target-to-575-msft-stock-news, https://www.gurufocus.com/news/3209758/wells-fargo-raises-nvidia-nvda-price-target-to-265-nvda-stock-news, https://www.gurufocus.com/news/3228857/morgan-stanley-adjusts-nvidia-nvda-price-target-to-250-nvda-stock-news, https://www.gurufocus.com/news/4106624/googl-wells-fargo-raises-alphabets-target-price-to-350-googl-stock-news, https://www.gurufocus.com/news/4109066/googl-goldman-sachs-maintains-buy-rating-raises-price-target-googl-stock-news, https://www.gurufocus.com/news/8599176/amzn-citigroup-lowers-price-target-but-maintains-buy-rating-amzn-stock-news, https://www.investing.com/news/analyst-ratings/alphabet-stock-price-target-raised-to-205-from-185-at-morgan-stanley-93CH-4143076, https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-lowered-to-286-by-bofa-on-aws-outlook-93CH-4466651, https://www.investing.com/news/analyst-ratings/broadcom-stock-holds-buy-rating-at-goldman-sachs-on-ai-momentum-93CH-4226196, https://www.investing.com/news/analyst-ratings/broadcom-stock-price-target-raised-to-500-by-bofa-on-ai-growth-93CH-4405225, https://www.investing.com/news/analyst-ratings/goldman-sachs-lifts-meta-stock-price-target-to-765-93CH-3838716, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-tsmc-stock-price-target-to-nt2100-on-ai-growth-outlook-93CH-4434161, https://www.investing.com/news/analyst-ratings/jpmorgan-reiterates-overweight-rating-on-broadcom-stock-amid-strong-ai-demand-93CH-4128085, https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-lowered-to-754-at-wells-fargo-93CH-4463247, https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-maintained-at-655-by-goldman-sachs-93CH-4454081, https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-700-from-675-at-wells-fargo-93CH-4318741, https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158, https://www.investing.com/news/analyst-ratings/nvidia-stock-rating-reiterated-by-jpmorgan-on-strong-data-center-demand-93CH-4224594, https://www.investing.com/news/analyst-ratings/tsmc-stock-price-target-raised-to-nt1400-by-citi-on-strong-2q25-results-4140181, https://www.investing.com/news/analyst-ratings/tsmc-stock-price-target-raised-to-nt2360-by-bofa-on-tech-leadership-93CH-4450329, https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-overweight-rating-on-apple-stock-amid-china-gains-93CH-4423681, https://www.investing.com/news/stock-market-news/citi-raises-apple-price-target-on-firmer-upgrade-cycle-iphone-17-strength-4398652, https://www.investopedia.com/meta-called-a-top-pick-by-citi-analysts-on-digital-ad-strength-11760351, https://www.investors.com/news/technology/apple-stock-price-target-cut-morgan-stanley/, https://www.marketbeat.com/instant-alerts/alphabet-nasdaqgoogl-given-new-39500-price-target-at-jpmorgan-chase-co-2026-02-05/, https://www.marketbeat.com/instant-alerts/apple-nasdaqaapl-price-target-raised-to-31500-at-jpmorgan-chase-co-2026-01-26/, https://www.marketbeat.com/instant-alerts/bank-of-america-cuts-microsoft-nasdaqmsft-price-target-to-52000-2026-01-26/, https://www.marketbeat.com/instant-alerts/citigroup-issues-positive-forecast-for-alphabet-nasdaqgoogl-stock-price-2026-02-06/, https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-given-new-63500-price-target-at-citigroup-2026-01-29/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.nasdaq.com/articles/morgan-stanley-maintains-broadcom-avgo-overweight-recommendation, https://www.pricetargets.com/NASDAQ/TSLA/, https://www.streetinsider.com/Analyst+PT+Change/Amazon.com+%28AMZN%29+PT+Lowered+to+%24300+at+Morgan+Stanley/25958773.html, https://www.thestreet.com/investing/stocks/bank-of-america-resets-google-stock-forecast-post-earnings, https://www.thestreet.com/investing/stocks/goldman-sachs-stuns-with-taiwan-semiconductor-stock-price-target, https://www.tipranks.com/news/the-fly/amazon-com-price-target-lowered-to-265-from-305-at-jpmorgan-thefly, https://www.tipranks.com/news/the-fly/meta-platforms-price-target-raised-to-690-from-640-at-bofa, https://www.tipranks.com/news/the-fly/tesla-price-target-lowered-to-145-from-150-at-jpmorgan-thefly
- IPO Calendar: https://markets.financialcontent.com/stocks/article/bizwire-2025-12-23-motive-files-registration-statement-for-proposed-initial-public-offering?utm_source=openai, https://www.ft.com/content/e0c71b94-b761-496c-a251-f106cbb9353a?utm_source=openai, https://www.investing.com/news/stock-market-news/generate-biomedicines-files-for-proposed-ipo-432SI-4486168?utm_source=openai, https://www.investopedia.com/a-google-backed-software-company-could-join-next-year-s-ai-powered-ipo-rush-11875950?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/117045/US-IPO-Week-Ahead-Markets-set-for-a-quiet-week-post-Presidents%25E2%2580%2599-Day?utm_source=openai, https://www.renaissancecapital.com/Profile/TKVA/Salspera/IPO?utm_source=openai, https://www.sec.gov/Archives/edgar/data/0002100782/000119312526037799/ck0002100782-20260204.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/1646681/000162828025058773/motive-sx1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/1881567/000119312526022945/d39893dex11.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/1881567/000119312526043602/d39893ds1a.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/1881567/000119312526047686/d39893ds1a.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2100782/000119312526051761/generate_bio_s-1a_-_exh_.htm, https://www.streetinsider.com/SEC%2BFilings?before_id=25930438&utm_source=openai, https://www.tradingview.com/news/tradingview%3Ada0c18787f0f4%3A0-salspera-cancer-immunotherapy-developer-files-for-nasdaq-stock-market-ipo/?utm_source=openai
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-02-19 at 11:26 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI